Back
Alnylam Pharmaceuticals Vs. Hims & Hers Health Industry Stock Comparison
Sell
37
ALNY
Alnylam Pharmaceuticals
Last Price:
$256.66
Seasonality Move:
-4.38%
Buy
75
HIMS
Hims & Hers Health
Last Price:
$60.50
Seasonality Move:
-9.4%
Sell
37
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
-
The current Alnylam Pharmaceuticals [ALNY] share price is $256.45. The Score for ALNY is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
-
ALNY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
75
Hims & Hers Health (HIMS)
is a Buy
Is Hims & Hers Health a Buy, Sell or Hold?
-
The current Hims & Hers Health [HIMS] share price is $60.47. The Score for HIMS is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
-
HIMS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $256.45Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing slight selling pressure.
HIMS Stock Price Chart
What is Hims & Hers Health's stock price today?
-
The Hims & Hers Health share price today is $60.47Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and HIMS is experiencing slight selling pressure.
ALNY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.12 | Buy |
| Relative Strength Index (14 RSI): | 42.86 | Sell |
| Chaikin Money Flow: | -220973 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (253.87 - 278.45) | Sell |
| Bollinger Bands (100): | (245.33 - 280.27) | Sell |
HIMS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 6.57 | Buy |
| Relative Strength Index (14 RSI): | 87.68 | Buy |
| Chaikin Money Flow: | -15624062 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (26.88 - 45.76) | Buy |
| Bollinger Bands (100): | (19 - 35.5) | Buy |
ALNY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 270.14 | Sell |
| 20-day SMA: | 270.86 | Sell |
| 50-day SMA: | 255.02 | Buy |
| 200-day SMA: | 239.98 | Buy |
| 8-day EMA: | 267.09 | Sell |
| 20-day EMA: | 266.5 | Sell |
| 50-day EMA: | 261.13 | Sell |
| 200-day EMA: | 241.68 | Buy |
HIMS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 47.45 | Buy |
| 20-day SMA: | 38.73 | Buy |
| 50-day SMA: | 32.59 | Buy |
| 200-day SMA: | 22.63 | Buy |
| 8-day EMA: | 49.17 | Buy |
| 20-day EMA: | 41.38 | Buy |
| 50-day EMA: | 34.24 | Buy |
| 200-day EMA: | 24.01 | Buy |
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.09 per share, a decrease next quarter of $0.14 per share, an increase this year of $1.08 per share, and an increase next year of $2.81 per share.
Hims & Hers Health Earnings Growth & HIMS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.11 per share, and an increase next year of $0.12 per share.
Alnylam Pharmaceuticals Technical Analysis
| Feb 3 | Feb 4 | Feb 5 | Feb 6 | Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb | ||||||||||
| 03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Hims & Hers Health Technical Analysis
| Feb 3 | Feb 4 | Feb 5 | Feb 6 | Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb | ||||||||||
| 03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||